middle.news
Paradigm Advances Phase 3 Knee Osteoarthritis Trial with US Ethics Approval
2:30am on Monday 2nd of June, 2025 AEST
•
Healthcare
Read Story
Paradigm Advances Phase 3 Knee Osteoarthritis Trial with US Ethics Approval
2:30am on Monday 2nd of June, 2025 AEST
Key Points
Centralised US ethics approval obtained for PARA_OA_012 Phase 3 trial
Up to 55 US clinical sites planned with many preparing for start-up
First US patient enrolment expected in Q3 2025
Trial to enrol 466 patients with moderate to severe knee osteoarthritis
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
PAR
OPEN ARTICLE